Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiat. 1988;23(3):271–84.
Almeida O, Burton E, Ferrier N, McKeith I. Depression with late onset is associated with right frontal lobe atrophy. Psychol Med. 2003;33(4):675–81.
Araujo NB, Moraes HS, Silveira H, Arcoverde C, Vasques PE, Barca ML, et al. Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in AD. Arq Neuropsiquiatr. 2014;72(9):671–9.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Association; 2013.
American Psychiatric Publication. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Publication; 2013.
Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res. 2004;57(3):297–305.
Bak TH, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke’s Cognitive Examination. Pract Neurol. 2007;7(4):245–9.
Balsamo M, Cataldi F, Carlucci L, Padulo C, Fairfield B. Assessment of late-life depression via self-report measures: a review. Clin Interv Aging. 2018;13:2021.
Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. The Lancet. 2011;378(9789):403–11.
Baum CM, Edwards DF, Leavitt K, Grant E, Deuel RM. Performance components in senile dementia of the Alzheimer type: motor planning, language, and memory. Occup Therapy J Res. 1988;8(6):356–68.
Brodaty H. Antidepressant treatment in Alzheimer’s disease. The Lancet. 2011;378(9789):375–6.
Busch RM, Frazier TW, Haggerty KA, Kubu CS. Utility of the Boston Naming Test in predicting ultimate side of surgery in patients with medically intractable temporal lobe epilepsy. Epilepsia. 2005;46(11):1773–9.
Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, et al. The nature and determinants of neuropsychological functioning in late-lifedepression. Arch Gen Psychiatry. 2004;61(6):587–95.
De Leon M, George A, Stylopoulos L, Smith G, Miller D. Early marker for Alzheimer’s disease: the atrophic hippocampus. The Lancet. 1989;334(8664):672–3.
Dhikav V, Sethi M, Anand K. Medial temporal lobe atrophy in Alzheimer’s disease/mild cognitive impairment with depression. Br J Radiol. 2014;87(1042):20140150.
Eker C, Gonul AS. Volumetric MRI studies of the hippocampus in major depressive disorder: meanings of inconsistency and directions for future research. London: Taylor & Francis; 2010.
Enache D, Cavallin L, Lindberg O, Farahmand B, Kramberger MG, Westman E, et al. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease. J Geriatr Psychiatry Neurol. 2015;28(1):40–8.
Fahlander K, Berger A-K, Wahlin Å, Bäckman L. Depression does not aggravate the episodic memory deficits associated with Alzheimer’s disease. Neuropsychology. 1999;13(4):532.
Ferris SH, Farlow M. Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors. Clin Interv Aging. 2013;8:1007.
Fox N, Warrington E, Freeborough P, Hartikainen P, Kennedy A, Stevens J, Rossor MN. Presymptomatic hippocampal atrophy in Alzheimer’s disease: a longitudinal MRI study. Brain. 1996;119(6):2001–7.
Gallassi R, Morreale A, Pagni P. The relationship between depression and cognition. Arch Gerontol Geriatr. 2001;33:163–71.
Gonzales-Salvdor T, Lyketsos C, Baker A, Roques C, Hovanek L, Steele C. Quality of life of patients with dementia in long-term care. Int J Geriatr Psychiatry. 2000;15:181–9.
Goodglass H, Wingfield A. Anomia: neuroanatomical and cognitive correlates. London: Academic Press; 1997.
Harlow LL, Newcomb MD, Bentler PM. Depression, self-derogation, substance use, and suicide ideation: Lack of purpose in life as a mediational factor. J Clin Psychol. 1986;42(1):5–21.
Hofman M, Seifritz E, Kräuchi K, Hock C, Hampel H, Neugebauer A, Müller-Spahn F. Alzheimer’s disease, depression and normal ageing: merit of simple psychomotor and visuospatial tasks. Int J Geriatr Psychiatry. 2000;15(1):31–9.
Hughes CP, Berg L, Danziger W, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140(6):566–72.
Juottonen K, Laakso M, Insausti R, Lehtovirta M, Pitkänen A, Partanen K, Soininen H. Volumes of the entorhinal and perirhinal cortices in Alzheimer’s disease. Neurobiol Aging. 1998;19(1):15–22.
Kang Y, Na D, Hahn S. Seoul neuropsychological screening battery. Incheon: Human Brain Research & Consulting Co; 2003.
Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–9.
Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer’s disease. Arch Neurol. 1993;50(9):949–54.
Kim HJ, Moon YS, Son BK, Lee SK, Rho HJ, Kim DH. The utility of Korean version of the WHO five well-being index in evaluating depressive symptoms and quality of life in the aged dwelling in community. J Korean Geriatr Psychiatry. 2010;14(2):90–6.
Koenig AM, DeLozier IJ, Zmuda MD, Marron MM, Begley AE, Anderson SJ, et al. Neuropsychological functioning in the acute and remitted states of late-life depression. J Alzheimers Dis. 2015;45(1):175–85.
Ku HM, Kim JH, Kwon EJ, Kim SH, Lee HS, Ko HJ, et al. A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living (S-IADL). J Korean Neuropsychiatr Assoc. 2004;43(2):189–99.
Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein S. Neuropsychological correlates of apathy and depression in patients with dementia. Neurology. 1999;52(7):1403–1403.
Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean Version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K) clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci. 2002;57(1):P47–53.
Leong C. Antidepressants for depression in patients with dementia: a review of the literature. Consult Pharm. 2014;29(4):254–63.
Lichtenberg PA, Steiner DA, Marcopulos BA, Tabscott JA. Comparison of the Hamilton Depression Rating Scale and the Geriatric Depression Scale: detection of depression in dementia patients. Psychol Rep. 1992;70(2):515–21.
Lopez OL, Boller F, Becker JT, Miller M, Reynolds CF III. Alzheimer’s disease and depression: neuropsychological impairment and progression of the illness. Am J Psychiatry. 1990;147(7):855.
Lozupone M, La Montagna M, D’Urso F, Piccininni C, Sardone R, Dibello V, et al. Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder. Expert Opin Pharmacother. 2018;19(8):823–42.
Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry. 2003;60(7):737–46.
Lyketsos CG, Steele C, Galik E, Rosenblatt A, Steinberg M, Warren A, Sheppard J-M. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry. 1999;156(1):66–71.
McKinnon MC, Yucel K, Nazarov A, MacQueen GM. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci. 2009;34(1):41.
Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, et al. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. 2012;20(12):1036–44.
Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry. 2008;16(7):558–67.
Nelson JC, Devanand DP. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia: [See Editorial Comments by Eric J. Lenze, MD on pp 0000–0000]. J Am Geriatr Soc. 2011;59(4):577–85.
Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(2):125–8.
Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of antidepressants for depression in Alzheimer’s disease: systematic review and meta-analysis. J Alzheimers Dis. 2017;58(3):725–33.
Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry. 2008;16(2):168–74.
Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P. Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression. Am J Psychiatry. 1989;146(1):45–9.
Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, et al. Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol. 2013;70(3):383–9.
Roselli F, Tartaglione B, Federico F, Lepore V, Defazio G, Livrea P. Rate of MMSE score change in Alzheimer’s disease: influence of education and vascular risk factors. Clin Neurol Neurosurg. 2009;111(4):327–30.
Rozzini L, Chilovi BV, Conti M, Bertoletti E, Zanetti M, Trabucchi M, Padovani A. Efficacy of SSRIs on cognition of Alzheimer’s disease patients treated with cholinesterase inhibitors. Int Psychogeriatr. 2010;22(1):114–9.
Rubio A, Vestner AL, Stewart JM, Forbes NT, Conwell Y, Cox C. Suicide and Alzheimer’s pathology in the elderly: a case–control study. Biol Psychiat. 2001;49(2):137–45.
Schweitzer I, Tuckwell V, Ames D. Structural neuroimaging studies in late-life depression: a review. World J Biol Psychiatry. 2001;2(2):83–8.
Sepehry AA, Lee PE, Hsiung GYR, Beattie BL, Jacova C. Effect of selective serotonin reuptake inhibitors in Alzheimer’s disease with comorbid depression. Drugs Aging. 2012;29(10):793–806.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(20):22–33.
Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci. 1996;93(9):3908–13.
Small JA, Sandhu N. Episodic and semantic memory influences on picture naming in Alzheimer’s disease. Brain Lang. 2008;104(1):1–9.
留言 (0)